Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 33.66 USD -11.86% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Rxsight Inc?
Write Note

Wall Street
Price Targets

RXST Price Targets Summary
Rxsight Inc

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 64.26 USD with a low forecast of 56.56 USD and a high forecast of 73.5 USD.

Lowest
Price Target
56.56 USD
68% Upside
Average
Price Target
64.26 USD
91% Upside
Highest
Price Target
73.5 USD
118% Upside

RXST Last Price Targets
Rxsight Inc

The latest public price target was made on Oct 29, 2024 by Anthony Crowdell from Mizuho Securities , who expects RXST stock to rise by 99% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Anthony Crowdell
Mizuho Securities
67 USD
Upside 99%
1 month ago
Oct 29, 2024
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga
Curry Baker
Guggenheim
52 USD
Upside 54%
1 month ago
Oct 29, 2024
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga
Adam Seiden
Barclays
110 USD
Upside 227%
1 month ago
Oct 29, 2024
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga
Young Li
Jefferies
72 USD
Upside 114%
1 month ago
Oct 29, 2024
Jefferies Starts RxSight Inc. (RXST) at Buy
StreetInsider
Ryan Zimmerman
BTIG
59 USD
Upside 75%
3 months ago
Sep 23, 2024
BTIG Reiterates Buy Rating on RxSight Inc. (RXST)
StreetInsider
David Saxon
Needham
66 USD
Upside 96%
3 months ago
Sep 13, 2024
Needham Reiterates Buy Rating on RxSight Inc. (RXST)
StreetInsider
David Saxon
Needham
54 USD
Upside 60%
4 months ago
Aug 6, 2024
RxSight Inc. (RXST) PT Lowered to $54 at Needham
StreetInsider
Thomas Stephan
Stifel Nicolaus
65 USD
Upside 93%
4 months ago
Aug 6, 2024
RxSight Analysts Slash Their Forecasts After Q2 Results
Benzinga
Ryan Zimmerman
BTIG
72 USD
Upside 114%
7 months ago
May 7, 2024
RxSight Inc. (RXST) PT Raised to $72 at BTIG
StreetInsider
David Saxon
Needham
75 USD
Upside 123%
7 months ago
May 7, 2024
RxSight Inc. (RXST) PT Raised to $75 at Needham
StreetInsider
Steven Lichtman
Oppenheimer
72 USD
Upside 114%
7 months ago
May 7, 2024
RxSight Inc. (RXST) PT Raised to $72 at Oppenheimer
StreetInsider
Lawrence Biegelsen
Wells Fargo
68 USD
Upside 102%
7 months ago
May 7, 2024
RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo
StreetInsider
Tom Stephan
Stifel Nicolaus
75 USD
Upside 123%
7 months ago
May 7, 2024
RxSight Inc. (RXST) PT Raised to $75 at Stifel
StreetInsider
Thomas Stephan
Stifel Nicolaus
68 USD
Upside 102%
7 months ago
May 6, 2024
RxSight price target raised to $68 from $64 at Stifel
TheFly
Lawrence Biegelsen
Wells Fargo
42 USD
Upside 25%
1 year ago
Dec 13, 2023
Wells Fargo Upgrades RxSight Inc. (RXST) to Overweight
StreetInsider
David Saxon
Needham
34 USD
Upside 1%
1 year ago
Jul 12, 2023
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
Benzinga
Show More Price Targets
Show Less Price Targets
Anthony Crowdell
Mizuho Securities
Price Target 67 USD
Upside/Downside 99%
View Source
Curry Baker
Guggenheim
Price Target 52 USD
Upside/Downside 54%
View Source
Adam Seiden
Barclays
Price Target 110 USD
Upside/Downside 227%
View Source
Young Li
Jefferies
Price Target 72 USD
Upside/Downside 114%
View Source
Ryan Zimmerman
BTIG
Price Target 59 USD
Upside/Downside 75%
View Source
David Saxon
Needham
Price Target 66 USD
Upside/Downside 96%
View Source
David Saxon
Needham
Price Target 54 USD
Upside/Downside 60%
View Source
Thomas Stephan
Stifel Nicolaus
Price Target 65 USD
Upside/Downside 93%
View Source
Ryan Zimmerman
BTIG
Price Target 72 USD
Upside/Downside 114%
View Source
David Saxon
Needham
Price Target 75 USD
Upside/Downside 123%
View Source
Steven Lichtman
Oppenheimer
Price Target 72 USD
Upside/Downside 114%
View Source
Lawrence Biegelsen
Wells Fargo
Price Target 68 USD
Upside/Downside 102%
View Source
Tom Stephan
Stifel Nicolaus
Price Target 75 USD
Upside/Downside 123%
View Source
Thomas Stephan
Stifel Nicolaus
Price Target 68 USD
Upside/Downside 102%
View Source
Lawrence Biegelsen
Wells Fargo
Price Target 42 USD
Upside/Downside 25%
View Source
David Saxon
Needham
Price Target 34 USD
Upside/Downside 1%
View Source
Show More Price Targets
Show Less Price Targets
Rxsight Inc Competitors:
Price Targets
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
33% Upside
603658
Autobio Diagnostics Co Ltd
33% Upside
7730
Mani Inc
32% Upside
HAE
Haemonetics Corp
50% Upside
LNTH
Lantheus Holdings Inc
53% Upside
300888
Winner Medical Co Ltd
14% Downside
STAA
STAAR Surgical Co
74% Upside
FIGS
Figs Inc
2% Upside

Revenue
Forecast

Revenue Estimate
Rxsight Inc

For the last 3 years the compound annual growth rate for Rxsight Inc's revenue is 82%. The projected CAGR for the next 4 years is 34%.

82%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXST's stock price target?
Price Target
64.26 USD

According to Wall Street analysts, the average 1-year price target for RXST is 64.26 USD with a low forecast of 56.56 USD and a high forecast of 73.5 USD.

What is Rxsight Inc's Revenue forecast?
Projected CAGR
34%

For the last 3 years the compound annual growth rate for Rxsight Inc's revenue is 82%. The projected CAGR for the next 4 years is 34%.

Back to Top